CVI Investments, Inc. 13D/13G Filings for Ensysce Biosciences, Inc. (ENSC)

CVI Investments, Inc. 13D and 13G filings for Ensysce Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
11:20 am
Sale		 2022-12-31 13G Ensysce Biosciences, Inc.
ENSC		 CVI Investments, Inc. 1,872
4.900%		 -906decrease
(-32.63%)		 Filing
2022-12-16
10:24 am
Purchase		 2022-12-07 13G Ensysce Biosciences, Inc.
ENSC		 CVI Investments, Inc. 2,778
7.800%		 2,778increase
(New Position)		 Filing